Moreover, CXCL1, CXCL9, β-NGF, C-peptide, GIP and adiponectin are higher only in CHC patients in agreement with previous studies in which these molecules were found elevated only in diabetic patients with complications (nephropathy, retinopathy and atherosclerotic lesions) [28]–[32]. This evidence concerns the gene CXCL9 and Atherosclerotic lesion.